keyword
https://read.qxmd.com/read/38644032/cytokine-storm-in-chikungunya-can-we-call-it-multisystem-inflammatory-syndrome-associated-with-chikungunya
#1
Zoilo Morel, Tamara Martínez, Fernando Galeano, Judith Coronel, Lorena Quintero, Rolando Jimenez, Jorge Ayala, Sara Amarilla, Dolores Lovera, Celia Martínez de Cuellar
Paraguay is currently facing a new outbreak of Chikungunya virus. This report summarizes two severe cases of Chikungunya (CHIKV) infection, confirmed by real-time reverse transcription polymerase chain reaction. We present the cases of patients with acute CHIKV infection and multisystem involvement, with fever, rash, abdominal pain, vomiting, myocarditis, and coronary artery anomalies, very similar to the cases described in MIS-C related to SARS-CoV-2 during the COVID-19 Pandemic. Both patients received IVIG and methylprednisolone, with good clinical response...
April 2024: Reumatología clinica
https://read.qxmd.com/read/38464895/subcutaneous-anakinra-in-the-management-of-refractory-mis-c-in-france
#2
JOURNAL ARTICLE
Perrine Dusser, Alexandre Belot, Fanny Bajolle, Charlotte Kevorkian-Verguet, Ulrich Meinzer, Frédéric Huet, Soizic Tiriau, Isabelle Kone-Paut
INTRODUCTION: Multisystemic inflammatory syndrome in children (MIS-C) is a therapeutic emergency and can lead to myocardial dysfunction (17%-75%) and heart failure (52%-53%). Intravenous immunoglobulins (IVIG) and corticosteroids (CST) have been validated for the management of this condition. Recent reports suggest that an interleukin-1 (IL-1) receptor antagonist, namely anakinra, may be a valuable add-on to the 2019 novel coronavirus disease (COVID-19) treatment for refractory patients...
2024: Frontiers in Pediatrics
https://read.qxmd.com/read/38425771/cardiac-arrest-in-seronegative-idiopathic-inflammatory-myopathy-a-case-report
#3
Varun Srivatsav, Ambreen Khan, Stephan Wardell
BACKGROUND: Idiopathic inflammatory myopathies (IIMs) are autoimmune diseases that are characterized by muscle injury. These disorders can cause cardiomyopathy and heart failure, myocarditis, and arrhythmias. However, only a few cases of cardiac arrest as a result of IIMs have been previously reported. CASE SUMMARY: A 46-year-old male presented with an out-of-hospital ventricular fibrillation cardiac arrest. A diagnosis of IIM had been made through a muscle biopsy performed 2 years before presentation...
December 2023: European Heart Journal. Case Reports
https://read.qxmd.com/read/38233099/corticosteroid-resistant-immune-related-adverse-events-a-systematic-review
#4
JOURNAL ARTICLE
Eveline Daetwyler, Till Wallrabenstein, David König, Laura C Cappelli, Jarushka Naidoo, Alfred Zippelius, Heinz Läubli
Immune checkpoint inhibitor (ICI) treatment has become an important therapeutic option for various cancer types. Although the treatment is effective, ICI can overstimulate the patient's immune system, leading to potentially severe immune-related adverse events (irAEs), including hepatitis, colitis, pneumonitis and myocarditis. The initial mainstay of treatments includes the administration of corticosteroids. There is little evidence how to treat steroid-resistant (sr) irAEs. It is mainly based on small case series or single case reports...
January 17, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38214810/multisystem-inflammatory-syndrome-in-children-mis-c-a-nationwide-collaborative-study-in-the-greek-population
#5
JOURNAL ARTICLE
Stavroula Lampidi, Despoina Maritsi, Marietta Charakida, Irini Eleftheriou, Evangelia Farmaki, Nikos Spyridis, Konstantina Charisi, Petrina Vantsi, Filippos Filippatos, Kleopatra Skourti, Efimia Papadopoulou-Alataki, Kyriaki Papadopoulou-Legbelou, Parthena Kampouridou, Ioanna N Grivea, Eleni Vergadi, Despoina Gkentzi, Despina Dimou, Patra Koletsi, Lampros Fotis, Theodota Liakopoulou, Aikaterini Agrafiotou, Katerina Kourtesi, Georgios Tsolas, Dimitrios Kafetzis, Vassiliki Papaevangelou, Gabriel Dimitriou, Emmanouil Galanakis, George A Syrogiannopoulos, Vassiliki Spoulou, Athanasios Michos, Emmanuel Roilides, Maria N Tsolia
UNLABELLED: Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe hyperinflammatory condition that may occur following SARS-CoV-2 infection. This retrospective, descriptive study of children hospitalized with multisystem inflammatory syndrome in children (MIS-C) in 12 tertiary care centers from 3/11/2020 to 12/31/2021. Demographics, clinical and laboratory characteristics, treatment and outcomes are described. Among 145 patients (95 males, median age 8.2 years) included, 123 met the WHO criteria for MIS-C, while 112 (77%) had serological evidence of SARS-CoV-2 infection...
January 12, 2024: European Journal of Pediatrics
https://read.qxmd.com/read/38051685/pembrolizumab-induced-peripheral-nervous-system-damage-a-combination-of-myositis-myasthenia-overlap-syndrome-and-motor-axonal-polyneuropathy
#6
Çakar Arman, Kamaci Ibrahim, Orhan Kocasoy Elif, Durmuş Hacer, Parman Yeşim
<p><strong>Introduction</strong> - Immune-checkpoint inhibitors (ICI) are effective drugs in cancer treatment that block immune checkpoints and stimulate an attack on cancer cells. However, various side effects were reported with ICIs. Peripheral nervous system (PNS) side effects are three times more frequent than those in the central nervous system.<br><strong>Case report </strong>-<strong> </strong>A 63-year-old male patient was admitted to our department with a 10-day history of dyspnea, diplopia, and generalized weakness...
November 30, 2023: Ideggyógyászati Szemle
https://read.qxmd.com/read/37680779/a-case-of-severe-cardiomyopathy-due-to-covid-induced-myocarditis-completely-resolved-after-colchicine-and-immunoglobulin-therapy
#7
JOURNAL ARTICLE
Su Khine, Srujan Edupuganti, Ghassan Bachuwa
UNLABELLED: Coronavirus 19 (COVID-19) is well known for causing acute respiratory distress syndrome. Among other systemic complications, myocarditis is a frequently reported presentation as well as complication. One systematic review reported a 14% mortality rate in patients with COVID-19 myocarditis. Endomyocardial biopsy is a definitive diagnostic test but has been a challenge to perform in most cases of COVID myocarditis due to the contagious nature of the disease. Patients presenting with new cardiomyopathy with troponin leak and arrhythmias, supported by recent COVID-19 diagnosis should be suspected for COVID-induced myocarditis...
2023: European Journal of Case Reports in Internal Medicine
https://read.qxmd.com/read/37662542/outbreak-of-severe-myocarditis-in-england-havoc-by-a-harmless-virus
#8
JOURNAL ARTICLE
Heeba Anis, Akbar Basha Shaik, Angad Tiwari, Abel Alemayehu, Abubakar Nazir, Linda Atulinda, Magda Wojtara, Olivier Uwishema
BACKGROUND: The World Health Organization (WHO) has been alerted to a concerning upsurge of severe myocarditis, an inflammatory heart condition, in neonates within Wales and South West England. The myocarditis cases are being intricately associated with enterovirus infection, belonging to the Picornaviridae family. The concerned pathogen poses a significant global disease burden, with an estimated 10 to 15 million symptomatic cases occurring annually in the United States alone. Neonates are particularly vulnerable with children under the age of one accounting for approximately 40% of enterovirus infections...
September 2023: Health Science Reports
https://read.qxmd.com/read/37572133/improved-outcomes-with-early-immunosuppression-in-patients-with-immune-checkpoint-inhibitor-induced-myasthenia-gravis-myocarditis-and-myositis-a-case-series
#9
REVIEW
Jamie Mj Weaver, Katie Dodd, Tom Knight, Mehek Chaudhri, Raj Khera, James B Lilleker, Mark Roberts, Paul Lorigan, Tim Cooksley
PURPOSE: Myasthenia gravis (MG) is a rare but life-threatening complication of immune-checkpoint inhibitor (ICI) therapy and often co-presents with myositis and myocarditis. Previous case series of ICI-related MG have reported high mortality rates. We present a series of ten patients from a tertiary oncology centre outlining outcomes of an early multi-modal immunosuppression strategy. METHODS: We reviewed The Christie Hospital database of immunotherapy-related toxicity from 2017 to 2020...
August 12, 2023: Supportive Care in Cancer
https://read.qxmd.com/read/37285523/mogamulizumab-associated-myositis-with-and-without-myasthenia-gravis-and-or-myocarditis-in-patients-with-t-cell-lymphoma
#10
JOURNAL ARTICLE
Cesar A Virgen, Jeffrey A Sparks, Anju Nohria, Meabh J O'Hare, Amrita Goyal, Jordan T Said, Marianne Tawa, Nicole R LeBoeuf, Thomas S Kupper, David C Fisher, Cecilia Larocca
Mogamulizumab is being increasingly prescribed for the treatment of T-cell lymphomas (MF/SS/ATLL). We conducted a retrospective cohort study to identify muscular immune-related adverse events (irAEs) associated with mogamulizumab in patients with T-cell lymphoma followed at Dana-Farber Cancer Institute from January 2015 to June 2022. We identified 5 cases of mogamulizumab-associated myositis and/or myocarditis (MAM/Mc), 2 additionally affected by myasthenia gravis, among 42 patients with T-cell lymphoma. Three cases experienced -mogamulizumab-associated rash (MAR) prior to developing MAM/Mc...
June 7, 2023: Oncologist
https://read.qxmd.com/read/37168408/clinical-course-and-outcome-of-cardiovascular-manifestations-in-children-with-multisystem-inflammatory-syndrome-associated-with-sars-cov-2-infection-in-georgia
#11
JOURNAL ARTICLE
Sofia Phirtskhalava, Elene Shavgulidze, Aadil Ashraf Ahmed Shaikh, Farah Marikar, Ketevan Kalatozishvili, Ana Maghradze, Ivane Chkhaidze
A SARS-CoV-2 infection is usually characterized by a very mild clinical course in the pediatric population. However, children can be severely affected, and clinical manifestations may differ from adults, mainly in terms of post-COVID-19 infection complications already known as multisystem inflammatory syndrome in children (MIS-C). As the name suggests, this condition involves many systems, including the cardiovascular system, clinical manifestations of which include myocarditis, coronary artery aneurysms, conduction abnormalities, and arrhythmias...
May 2023: Curēus
https://read.qxmd.com/read/37090278/multisystem-inflammatory-syndrome-causing-mixed-cardiogenic-shock-in-a-34-year-old-with-influenza-a
#12
Simon Kashfi, Matthew Pierce
Multisystem inflammatory syndrome in adults (MIS-A) is a sequela of COVID-19 and can cause mixed cardiogenic and vasodilatory shock. We present the case of a 34-year-old female who presented with mixed cardiogenic and vasodilatory shock and was found to be influenza A positive while also meeting criteria for MIS-A. She responded well to treatment with steroids and intravenous immunoglobulin (IVIG).
March 2023: Curēus
https://read.qxmd.com/read/36859277/multisystem-inflammatory-syndrome-in-children-associated-with-bacille-calmette-gu%C3%A3-rin-scar-a-case-presentation
#13
JOURNAL ARTICLE
Hilal Kizildag, Kristin Joanna Hannavi, Rana Gur, Kazim Oztarhan
BACKGROUND: During Coronavirus disease of 2019 (COVID-19) pandemic, the WHO reported a noticeable increase in Kawasaki disease prevalence in countries where Kawasaki disease is rare. This newly seen disease, unlike typical Kawasaki disease, tends to appear at a later age, has prominent gastrointestinal findings, higher rates of myocarditis and coronary artery involvement and a greater need for admission to the intensive care unit (ICU). Induration of the Bacillus Calmette-Guerin (BCG) scar is a rare finding seen in multisystem inflammatory syndrome (MIS-C)...
March 1, 2023: BMC Pediatrics
https://read.qxmd.com/read/36776728/covid-19-associated-fulminant-myocarditis-in-a-fully-vaccinated-female-a-case-report-with-clinical-follow-up
#14
Parham Samimisedeh, Fatemeh Sehati, Elmira Jafari Afshar
BACKGROUND: Myocarditis is considered a serious adverse event after COVID-19 infection. The risk and severity of myocarditis after COVID-19 disease decreased significantly in the vaccinated population. We present a case of cardiac magnetic resonance proven fulminant myocarditis following COVID-19 disease in a young female who was previously vaccinated with 2 doses of the BIBP (Sinopharm) vaccine. CASE SUMMARY: A 29-year-old female was referred to the hospital with acute chest pain, dyspnea, and nausea...
2023: Clinical Medicine Insights. Case Reports
https://read.qxmd.com/read/36720714/describing-our-experience-with-the-effects-of-multisystem-inflammatory-syndrome-in-children-with-covid-19-on-the-cardiovascular-system
#15
JOURNAL ARTICLE
Norane Shehab, Robert F English
Cardiac involvement with multisystem inflammatory syndrome in children can include coronary artery abnormalities, ventricular dysfunction, conduction abnormalities, arrhythmias, pericarditis, and myocarditis. We report the cardiac findings in 34 patients with multisystem inflammatory syndrome in children admitted to a single institution. We looked at patient age, sex, brain natriuretic peptide levels, troponin levels, ejection fraction, presence of pericardial effusion, valvular changes, need for inotropic agents, and electrocardiogram findings...
February 1, 2023: Cardiology in the Young
https://read.qxmd.com/read/36636445/delayed-diagnosis-and-recovery-of-fulminant-immune-checkpoint-inhibitor-associated-myocarditis-on-va-ecmo-support
#16
REVIEW
Tarun Ramayya, Joshua D Mitchell, Justin C Hartupee, Kory Lavine, Clare H Ridley, Kunal D Kotkar, Jesus Jimenez, Chieh-Yu Lin, Jose A Alvarez-Cardona, Ronald K Krone, Courtney M Campbell
No abstract text is available yet for this article.
December 2022: JACC CardioOncology
https://read.qxmd.com/read/36471327/similarities-and-differences-between-mis-c-and-kd-a-systematic-review-and-meta-analysis
#17
REVIEW
Tong Tong, Xuefeng Yao, Zhe Lin, Yijing Tao, Jiawen Xu, Xiao Xu, Zhihao Fang, Zhimin Geng, Songling Fu, Wei Wang, Chunhong Xie, Yiying Zhang, Yujia Wang, Fangqi Gong
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a new syndrome with some clinical manifestations similar to Kawasaki disease (KD), which is difficult to distinguish. OBJECTIVE: The study aimed to characterize the demographic characteristics, clinical characteristics, laboratory features, cardiac complications, and treatment of MIS-C compared with KD. STUDY DESIGN: Studies were selected by searching the PubMed, EMBASE and so on before February 28, 2022...
December 5, 2022: Pediatric Rheumatology Online Journal
https://read.qxmd.com/read/36457566/myocarditis-and-myositis-myasthenia-gravis-overlap-syndrome-induced-by-immune-checkpoint-inhibitor-followed-by-esophageal-hiatal-hernia-a-case-report-and-review-of-the-literature
#18
Beibei Yin, Junjuan Xiao, Xuan Wang, Xingyu Li, Yaping Guan, Jinghua Chen, Pengxi Han, Kun Li, Jun Wang
Immunotherapy with programmed death 1 (PD-1) inhibitor has shown activity as first- or second-line treatment for various metastatic human malignancies. Immune-related adverse events (irAEs) are now well-described, and most organ sites are potentially influenced, but the prevalence of myocarditis and myositis/myasthenia gravis (MG) overlap syndrome following esophageal hiatal hernia induced by immunotherapy is rarely reported. Here, we describe a 71-year-old woman with a progressed unresectable extrahepatic cholangiocarcinoma and biliary obstruction...
2022: Frontiers in Medicine
https://read.qxmd.com/read/36205853/patients-with-fulminant-myocarditis-supported-with-veno-arterial-extracorporeal-membrane-oxygenation-a-systematic-review-and-meta-analysis-of-short-term-mortality-and-impact-of-risk-factors
#19
REVIEW
Julie K K Vishram-Nielsen, Farid Foroutan, Saima Rizwan, Serena S Peck, Julia Bodack, Ani Orchanian-Cheff, Finn Gustafsson, Heather J Ross, Eddy Fan, Vivek Rao, Filio Billia, Ana Carolina Alba
Fulminant myocarditis (FM) may lead to cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Results of effectiveness studies of VA-ECMO have been contradictory. We evaluated the aggregate short-term mortality after VA-ECMO and predictive factors in patients with FM. We systematically searched in electronic databases (February 2022) to identify studies evaluating short-term mortality (defined as mortality at 30 days or in-hospital) after VA-ECMO support for FM. We included studies with 5 or more patients published after 2009...
March 2023: Heart Failure Reviews
https://read.qxmd.com/read/36186650/myoglobin-and-left-ventricular-ejection-fraction-as-predictive-markers-for-death-in-children-with-fulminant-myocarditis
#20
JOURNAL ARTICLE
Tingting Xie, Xiaodong Zang, Yingying Xiong, Chaolei Yang, Fei Li, Dandan Wang, Yaqin Shu, Xuming Mo, Mingwu Chen
Background: Fulminant myocarditis (FM) is an inflammatory process of the myocardium and an important cause of cardiac dysfunction in children; it is characterized by rapid onset, acute progression, and high mortality. The study sought to describe the clinical characteristics and prognostic factors in children with FM. Methods: The study population consists of 37 consecutive patients admitted from May 2014 to December 2021 with a diagnosis of FM. According to the prognosis of children with FM during hospitalization, they were divided into "survival" group (25 cases) and "death" group (12 cases)...
2022: Frontiers in Pediatrics
keyword
keyword
117159
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.